Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. There have been very few developments in its diagnosis and treatment over the past decades. It is urgently needed to explore potential novel biomarkers and drug targets for SCLC.Methods: Two-sample Mendelian Randomization (MR) was performed to investigate causal associations between SCLC and plasma proteins using genome-wide association studies (GWAS) summary statistics of SCLC from Transdisciplinary Research Into Cancer of the Lung Consortium (nCase = 2,791 vs. nControl = 20,580), and was validated in another cohort (nCase = 2,664 vs. nControl = 21,444). 734 plasma proteins and their genetic instruments of cis-acting protein quantitative trait...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Small cell lung cancer (SCLC) is a carcinoma of the lungs with strong invasion, poor prognosis and r...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
INTRODUCTION: Small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, with no e...
Small-cell-lung cancer (SCLC) is associated with overexpression of oncogenes including Myc family ge...
Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Ne...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Small cell lung cancer (SCLC) is a carcinoma of the lungs with strong invasion, poor prognosis and r...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. Th...
INTRODUCTION: Small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, with no e...
Small-cell-lung cancer (SCLC) is associated with overexpression of oncogenes including Myc family ge...
Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Ne...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all patients wit...
Small cell lung cancer (SCLC) is a carcinoma of the lungs with strong invasion, poor prognosis and r...
Purpose: Pretreatment selection of patients with non-small cell lung cancer (NSCLC) who would derive...